4//SEC Filing
Pierce Christopher 4
Accession 0001209191-20-052400
CIK 0001678660other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 8:07 PM ET
Size
4.7 KB
Accession
0001209191-20-052400
Insider Transaction Report
Form 4
Pierce Christopher
EVP and Chief of Business Oper
Transactions
- Purchase
Common Stock
2020-09-29$19.00/sh+3,750$71,250→ 3,750 total
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001824631
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 8:07 PM ET
- Size
- 4.7 KB